Insulin therapy has advanced remarkably over the past few decades. Ultra-rapid-acting and ultra-long-acting insulin analogs are now commercially available. Many additional insulin formulations are in development. This review outlines recent advances in insulin therapy and novel therapies in development.
No takes yet. Share an insight, caveat, or question.
Wilson et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: